As at May 3, 2024, the UTHR stock has a PE ratio of 11.74. This is based on the current EPS of $22.36 and the stock price of $262.4 per share. An increase of 6% has been seen in the P/E ratio compared to the average of 11.0 of the last 4 quarters.
The mean historical PE ratio of UNITED THERAPEUTICS over the last ten years is 14.51. The current 11.74 PE ratio is 19% below the historical average. Over the past ten years, UTHR's PE ratio was at its highest in the Jun 2015 quarter at 47.14, with a price of $173.95 and an EPS of $3.69. The Jun 2016 quarter recorded the bottom point at 4.74, with a price of $105.92 and an EPS of $22.35.
Maximum annual increase: 76.93% in 2017
Maximum annual decrease: -48.36% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 10.45 | -39.94% |
| 2022 | 17.4 | -14.62% |
| 2021 | 20.38 | 56.41% |
| 2020 | 13.03 | N/A |
| 2019 | N/A | N/A |
| 2018 | 8.04 | -48.36% |
| 2017 | 15.57 | 76.93% |
| 2016 | 8.8 | -20.36% |
| 2015 | 11.05 | -39.75% |
| 2014 | 18.34 | -43.4% |
Currently, UTHR's PE ratio is below the 3, 5 and 10-year averages.
UTHR's PE ratio is lower than its peer stocks LLY and PFE, but it is greater than BAX's. UNITED THERAPEUTICS is presently trading at a lower PE ratio (11.74) than its peer group average of 34.47.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BAX Baxter International Inc | 7.05 | $18.8B |
| UTHR UNITED THERAPEUTICS Corp | 11.74 | $11.64B |
| GILD Gilead Sciences Inc | 14.27 | $80.7B |
| CAH Cardinal Health Inc | 43.38 | $24.09B |
| PFE Pfizer Inc | 73.18 | $157.04B |
| LLY ELI LILLY & Co | 107.77 | $698.52B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $15.67B |
| CYTK Cytokinetics Inc | N/A | $6.72B |
As of May 3, 2024, UTHR stock has a price to earnings ratio of 11.74.
The 3-year average PE ratio for UTHR stock is 14.42.
The 5-year average PE ratio for UTHR stock is 13.77.
Over the last ten years, the quarterly PE ratio reached a historic high of 47.14 in the Jun 2015 quarter.
UTHR's current price to earnings ratio is 19% below its 10-year historical average.
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (May 3, 2024), UNITED THERAPEUTICS's stock price is $262.4. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $22.36. Therefore, UNITED THERAPEUTICS's P/E ratio for today is 11.74. PE RATIO(11.74) = STOCK PRICE($262.4) / TTM EPS($22.36)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.